AIDS and Behavior

, Volume 18, Issue 3, pp 525–534 | Cite as

Hazardous and Harmful use of Alcohol and/or Other Drugs and Health Status Among South African Patients Attending HIV Clinics

  • R. Kader
  • S. Seedat
  • R. Govender
  • J. R. Koch
  • C. D. Parry
Original Paper

Abstract

There is growing recognition of the influence of substance use, particularly alcohol use, on HIV disease progression. This study investigated how hazardous/harmful use of alcohol and drugs impacts the health status of 1503 patients attending HIV clinics. Of the sample, 37 % indicated hazardous/harmful drinking and 13 % indicated a drug problem. Hazardous/harmful use of alcohol and drugs was significantly related to health status, with participants using substances more likely to have TB-positive status (χ2 = 4.30, p < 0.05), less likely to be on ARVs (χ2 = 9.87, p < 0.05) and having lower CD4 counts (t = 4.01, p < 0.05). Structural equation modelling confirmed the centrality of hazardous/harmful use of alcohol as a direct and indirect determinant of disease progression. Based on these findings it is recommended that patients attending HIV clinics be routinely screened for problematic alcohol and/or drug use, with strong emphasis on ensuring ARV adherence in those with problematic alcohol use.

Keywords

Alcohol Drugs HIV ARV CD4 count 

Resumen

Existe un creciente reconocimiento de la influencia del consumo de sustancias, en particular el uso de alcohol, en la progresión de la enfermedad del VIH. Este estudio investigó cómo el uso riesgoso/nocivo de alcohol y drogas afecta el estado de salud de 1.503 pacientes que acuden a las clínicas de VIH. De la muestra, el 37 % indicó consumo riesgoso/nocivo y 13 % indicó un problema de drogas. El uso riesgoso/nocivo del alcohol y las drogas estuvo significativamente asociado con el estado de salud, con los participantes que usaron sustancias mostrando mayor probabilidades de tener TB positiva (c2 = 4.30, p < 0.05), menor probabilidad de estar en ARV (c2 = 9.87, p < 0.05) y que tiene más bajos recuentos de CD4 (t = 4.01, p < 0.05). Modelos de ecuaciones estructurales confirmaron la centralidad del consumo riesgoso/nocivo del alcohol como un determinante directo e indirecto de la progresión de la enfermedad. Basándose en estos resultados, se recomienda que los pacientes que asisten a clínicas de VIH se examinan rutinariamente para detectar alcohol problemático y/o el consumo de drogas, con un fuerte énfasis en asegurar la adherencia al ARV en los pacientes con consumo problemático de alcohol.

Palabras clave

Alcohol Drogas VIH ARV CD4 

References

  1. 1.
    UNAIDS: Report on the global AIDS epidemic 2010 Available at: http://www.unaids.org/globalreport/Global_report.htm (2010). Accessed 18 April 2013.
  2. 2.
    Department of Health. National Antenatal Sentinel HIV and Syphilis Prevalence in South Africa, 2009. Pretoria: Department of Health; 2010.Google Scholar
  3. 3.
    Shisana O, Rehle T, Simbayi LC, et al. South African National HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers? Cape Town: HSRC Press; 2009.Google Scholar
  4. 4.
    Townsend L, Rosenthal SR, Parry CDH, Zembe Y, Mathews C, Flisher AJ. Associations between alcohol misuse and risks for HIV infection among men who have multiple female sexual partners in Cape Town, South Africa. AIDS Care. 2010;22(12):1544–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Parry CDH, Pithey AL. Risk behaviour and HIV among drug using populations in South Africa. Afr J Drug Alcohol Stud. 2006;5(2):140–57.Google Scholar
  6. 6.
    Herman AL, Stein DJ, Seedat S, Heeringa SG, Moomal H, Williams DR. The South African Stress and Health (SASH) study: 12-month and lifetime prevalence of common mental disorders. S Afr Med J. 2009;99(5):339–44.PubMedCentralPubMedGoogle Scholar
  7. 7.
    Dada S, Plüddemann A, Parry C et al. Monitoring alcohol and drug abuse trends in South Africa (July 1996–December 2011). SACENDU Research Brief, 2012; 15(1): 1–15. Medical Research Council of South Africa.Google Scholar
  8. 8.
    Barroso J, Sandelowski M. Substance abuse in HIV positive women. J Assoc Nurses AIDS Care. 2004;15(5):48–59.PubMedCrossRefGoogle Scholar
  9. 9.
    Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180–202.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Molina PE, Happel KI, Zang P, Kolls JK, Nelson S. Focus on: alcohol and the immune system. Alcohol Res Health. 2010;33(1):97–108.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Rehm J, Samokhvalov AV, Neuman MG, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450. doi:1186/1471-2458-9-450.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Myer L, Smit J, Le Roux L, Parker S, Stein D, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care and STDs. 2008;22(2):147–58.PubMedCrossRefGoogle Scholar
  13. 13.
    Olley BO, Gxamza F, Seedat S, et al. Psychopathology and coping in recently diagnosed HIV/AIDS patients-the role of gender. S Afr Med J. 2003;93(12):928–31.PubMedGoogle Scholar
  14. 14.
    Freeman M, Nkomo N, Kafaar Z, Kelly K. Mental disorders in people living HIV/Aids in South Africa. S Afr J Psychiatry. 2008;38(3):489–500.Google Scholar
  15. 15.
    Goar SG, Audu MD, Agbir MT, Dochalson. Prevalence and socio-demographic correlates of alcohol use disorders among HIV patients. Afr J Drug Alcohol Stud. 2011;10(11):11–6.Google Scholar
  16. 16.
    Yunusa MA, Obembe A, Ibrahim T, Njoku CH. Prevalence and specific psychosocial factors associated with substance use and psychiatric morbidity among patients with HIV infection at Usmanu Danfodiyo University Teaching Hospital, Sokoto State, Nigeria. Afr J Drug Alcohol Stud. 2011;10(1):11–6.Google Scholar
  17. 17.
    Sacktor NC, Wong M, Nakasujja N, et al. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS. 2005;19:1367–74.PubMedGoogle Scholar
  18. 18.
    Berghuis JP, Uldall KK, Lalonde B. Validity of two scales in identifying HIV associated dementia. J Acquir Immune Defic Syndr. 1999;21(2):134–40.PubMedGoogle Scholar
  19. 19.
    Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT The Alcohol Use Disorders Identification Test: Guidelines for use in primary care. 2nd ed. Geneva: World Health Organization Department of Mental Health and Substance Dependence; 2001.Google Scholar
  20. 20.
    Peltzer K, Davids SA, Njuho P. Alcohol use and problem drinking in South Africa: findings from a national population-based survey. Afr J Psychiatry. 2011;14:30–7.CrossRefGoogle Scholar
  21. 21.
    Peltzer K, Naidoo P, Matseke G, Zuma K. Screening and brief interventions for hazardous and harmful alcohol use among patients with active tuberculosis attending primary care clinics in South Africa: a cluster randomized controlled trial protocol. BMC Public Health. 2011;4(11):394–402.CrossRefGoogle Scholar
  22. 22.
    Julia L, Peltzer K, Matseke G. Prevalence of alcohol use and associated factors in pregnant antenatal care attendees in Mpumalanga, South Africa. J Psychol Afr. 2011;21(4):567–72.Google Scholar
  23. 23.
    Berman AH, Bergman H, Palmstierna T, Schlyter F. DUDIT manual the drug use disorders identification test. London: Karolinska Institutet Department of Clinical Neuroscience; 2005.Google Scholar
  24. 24.
    Field A. Discovering statistics using SPSS. 3rd ed. London: SAGE Publications Ltd; 2009.Google Scholar
  25. 25.
    Global Status report on alcohol and health 2011. Geneva: World Health Organization. Available at: http://www.who.int/substance_abuse/publications/global_alcohol_report/en/ Accessed 18 April 2013.
  26. 26.
    Turner BJ, Fleishman JA, Wenger N, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med. 2001;16(9):625–33.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Thomas B, Suhadev M, Mani J, et al. Feasibility of an alcohol intervention programme for TB patients with alcohol use disorder (AUD)—a qualitative study from Chennai, South India. PLoS One. 2011;6(11):e27752.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Suhadev M, Thomas BE, Sakthivel R, et al. Alcohol use disorders (AUD) among tuberculosis patients: a study from Chennai, South India. PLoS One. 2011;6(5):e19485.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Azar MW, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112:178–93.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Malta M, Magnanini MMF, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2008. doi: 10.1007/s10461-008-9489-7.
  31. 31.
    Kader R, Seedat S, Koch JR, Parry CDH. A preliminary investigation of the AUDIT and DUDIT in comparison to biomarkers for alcohol and drug use among HIV-infected clinic attendees in Cape Town, South Africa. Afr J Psychiatry. 2012;15:346–51.CrossRefGoogle Scholar
  32. 32.
    Peretti-Watel P, Spire B, Lert F, Obadai Y. The Vespa Group. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN 12-VESPA 2003). Drug Alcohol Depend. 2006;82(1):71–9.CrossRefGoogle Scholar
  33. 33.
    Parry CDH, Rehm J, Morojele NK. Is there a causal relationship between alcohol and HIV? Implications for policy, practice and future research. Afr J Drug Alcohol Stud. 2010;9(2):81–91.Google Scholar
  34. 34.
    Parry CDH, Ferreira-Borges C, Poznyak V, Lonnroth K, Rehm J. The international study on alcohol and infectious diseases: three priorities for research. Addiction. 2012;108:1–2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • R. Kader
    • 1
  • S. Seedat
    • 1
  • R. Govender
    • 1
  • J. R. Koch
    • 1
  • C. D. Parry
    • 1
  1. 1.Alcohol and Drug Abuse Research Unit, Medical Research CouncilTygerberg, Cape TownSouth Africa

Personalised recommendations